Grove Biopharma is a startup based in the United States, 1 tracked investor.
Based in the United States, Grove Biopharma is a startup founded in 2024. Brouky records 1 investor associated with the company.
Grove Biopharma develops synthetic brush-like molecules called precision-linked proteomimetics designed to penetrate cell membranes and modulate intracellular protein-protein interactions to treat cancer and other diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.